Position in DXCM
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$3,300
+$3 QoQ
Shares Held
49
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#887
of 966 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $29,318,187 across 16 Medical Devices names. DXCM ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GEHC |
GE HealthCare Technologies Inc.
|
180,282 | $11,539,850 | |
| 2 | BSX |
Boston Scientific Corp
|
188,810 | $8,058,410 | |
| 3 | ABT |
Abbott Laboratories
|
61,261 | $5,558,823 | |
| 4 | SYK |
Stryker Corp
|
6,884 | $2,167,358 | |
| 5 | EW |
Edwards Lifesciences Corp
|
8,984 | $812,692 | |
| 6 | VMD |
Viemed Healthcare, Inc.
|
57,982 | $660,994 | |
| 7 | INFU |
InfuSystem Holdings, Inc
|
22,417 | $216,324 | |
| 8 | AORT |
Artivion, Inc.
|
5,600 | $125,832 |
All Filings in DXCM
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,300 | 49 | Shares | Sole | 2026-07-14 | |
| 2025-09-30 | $3,297 | 49 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $4,277 | 49 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $3,346 | 49 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $3,810 | 49 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $3,284 | 49 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $5,555 | 49 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $6,796 | 49 | Shares | Sole | 2024-04-11 | |
| 2020-12-31 | $1,109 | 3 | Shares | Sole | 2021-02-17 | |
| 2020-06-30 | $8,918 | 22 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,923 | 22 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||